Table 2.
Chronic self-reported diseases of the 584 participants at baseline, by antibody concentration.
| Total n = 585 | Antibody concentrations < 15 n = 139 | Antibody concentrations ≥15 n = 446 | p-value | |
|---|---|---|---|---|
| Multimorbidity | 0.410a | |||
| 0–1 | 463 (89.2%) | 114 (91.2%) | 349 (88.6%) | |
| ≥2 | 56 (10.8%) | 11 (8.8%) | 45 (11.4%) | |
| Diabetes (yes) | 28 (4.8%) | 5 (3.6%) | 23 (5.2%) | 0.649a |
| High blood pressure (yes) | 84 (14.4%) | 10 (7.2%) | 75 (16.8%) | 0.004 a |
| Cardiovascular (yes) | 25 (4.3%) | 2 (1.4%) | 22 (4.9%) | 0.089a |
| Respiratory diseases (yes) | 44 (7.5%) | 14 (10.1%) | 30 (6.7%) | 0.199a |
| Chronic renal failure (yes) | 9 (1.5%) | 1 (0.7%) | 8 (1.8%) | 0.693a |
| Cancer (yes) | 11 (1.9%) | 1 (0.72%) | 10 (2.2%) | 0.473a |
| Autoimmune Diseases (yes) | 29 (5.0%) | 8 (5.8%) | 21 (4.7%) | 0.655a |
| Others (yes) | 80 (13.7%) | 16 (11.5%) | 64 (14.4%) | 0.48a |
aFisher's exact test.
Statistically significant values are denoted in bold.
Sample size is not constant due to missing data.
Total: Number of comorbidities (n = 519); Diabetes (n = 519); High blood pressure (n = 519); Cardiovascular (n = 519); Respiratory diseases (n = 519); Chronic renal failure (n = 519); Cancer (n = 519); Autoimmune Diseases (n = 519); Others (n = 519).
Antibody concentrations < 15: Number of comorbidities (n = 125); Diabetes (n = 125); High blood pressure (n = 125); Cardiovascular (n = 125); Respiratory diseases (n = 125); Chronic renal failure (n = 125); Cancer (n = 125); Autoimmune Diseases (n = 125); Obesity (n = 125); Others (n = 125).
Antibody concentrations ≥15: Number of comorbidities (n = 394); Diabetes (n = 394); High blood pressure (n = 394); Cardiovascular (n = 394); Respiratory diseases (n = 394); Chronic renal failure (n = 394); Cancer (n = 394); Autoimmune Diseases (n = 394); Others (n = 394).